|
1
|
Classification of visual field abnormalities in the ocular hypertension treatment study.
|
Arch Ophthalmol
|
2003
|
1.76
|
|
2
|
Baseline visual field characteristics in the ocular hypertension treatment study.
|
Ophthalmology
|
2002
|
1.46
|
|
3
|
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
|
Ophthalmology
|
2006
|
1.16
|
|
4
|
Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.
|
Arch Ophthalmol
|
2010
|
1.01
|
|
5
|
Visual field quality control in the Ocular Hypertension Treatment Study (OHTS).
|
J Glaucoma
|
2007
|
0.97
|
|
6
|
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.
|
Arch Ophthalmol
|
2005
|
0.95
|
|
7
|
Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis.
|
J Neuroophthalmol
|
2013
|
0.82
|